Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-03-08
2005-03-08
Cook, Rebecca (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S456000
Reexamination Certificate
active
06864280
ABSTRACT:
The present invention provides a diuretic, sodium ion-excreting agent, medicament for preventing or treating hypertension, medicament for preventing or treating ischemic cardiac diseases, medicament for preventing or treating congestive cardiac insufficiency or medicament for preventing or treating renal diseases, which comprises γ-tocotrienol.
REFERENCES:
patent: 0 669 132 (1995-08-01), None
patent: 10-506383 (1998-06-01), None
patent: 11-049 767 (1999-02-01), None
patent: 9605191 (1996-02-01), None
patent: 9906040 (1999-02-01), None
Goodman & Gilman, The pharmacological basis of therapeutics, 5thedition, 1975, pp. 719-720.*
Newaz et al “Effect of γ-Tocotrienol on Blood Pressure, Lipid Peroxidation and Total Antioxidant Status in Spontaneously Hypertensive Rats (SHR)” ,Clinical and Experimental Hypertension, vol. 21, No. 8, Nov. 1999, pp. 1297-1313.
Igarashi Osamu
Kiyose Chikako
Yoshimura Hiroyuki
Yoshitake Shigehiro
Cook Rebecca
Eisai Co. Ltd.
Flynn ,Thiel, Boutell & Tanis, P.C.
LandOfFree
γ-Tocotrienol-containing diuretics does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with γ-Tocotrienol-containing diuretics, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and γ-Tocotrienol-containing diuretics will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3387541